Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome

Monitoring minimal residual disease (MRD) provides important information during treatment of hematologic malignancies. Chimerism analysis also provides key information after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recent advances in next-generation sequencing (NGS) have enabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong-Mi, Kim, Yoo-Jin, Park, Sung-Soo, Han, Eunhee, Kim, Myungshin, Kim, Yonggoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947461/
https://www.ncbi.nlm.nih.gov/pubmed/31795155
http://dx.doi.org/10.3390/jcm8122077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947461/
https://www.ncbi.nlm.nih.gov/pubmed/31795155
http://dx.doi.org/10.3390/jcm8122077

Ejemplares similares